Mylan ROA 2006-2018 | MYL

Current and historical return on assets (ROA) values for Mylan (MYL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Mylan ROA for the three months ending September 30, 2018 was 7.15%.
Mylan ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.55B $33.46B 1.59%
2018-06-30 $0.46B $33.27B 1.30%
2018-03-31 $0.72B $35.19B 2.01%
2017-12-31 $0.70B $35.81B 1.97%
2017-09-30 $0.87B $35.82B 2.48%
2017-06-30 $0.66B $35.51B 1.87%
2017-03-31 $0.53B $34.27B 1.58%
2016-12-31 $0.48B $34.73B 1.56%
2016-09-30 $0.26B $36.54B 0.93%
2016-06-30 $0.81B $28.84B 3.39%
2016-03-31 $0.81B $22.64B 3.62%
2015-12-31 $0.85B $22.27B 3.84%
2015-09-30 $0.84B $21.32B 4.11%
2015-06-30 $0.91B $22.80B 4.81%
2015-03-31 $0.87B $22.12B 5.06%
2014-12-31 $0.93B $15.82B 6.00%
2014-09-30 $0.92B $15.17B 5.99%
2014-06-30 $0.58B $15.60B 3.92%
2014-03-31 $0.63B $15.36B 4.54%
2013-12-31 $0.62B $15.30B 4.77%
2013-09-30 $0.61B $12.90B 4.95%
2013-06-30 $0.66B $12.21B 5.51%
2013-03-31 $0.62B $11.89B 5.25%
2012-12-31 $0.64B $11.93B 5.44%
2012-09-30 $0.61B $11.71B 5.19%
2012-06-30 $0.55B $11.60B 4.79%
2012-03-31 $0.56B $11.93B 4.81%
2011-12-31 $0.54B $11.60B 4.60%
2011-09-30 $0.41B $11.12B 3.52%
2011-06-30 $0.36B $12.01B 3.08%
2011-03-31 $0.27B $11.88B 2.34%
2010-12-31 $0.22B $11.54B 2.01%
2010-09-30 $0.22B $11.41B 2.05%
2010-06-30 $0.08B $10.60B 0.71%
2010-03-31 $0.08B $10.82B 0.78%
2009-12-31 $0.09B $10.80B 0.89%
2009-09-30 $0.03B $10.76B 0.33%
2009-06-30 $0.26B $10.24B 2.46%
2009-03-31 $0.18B $9.90B 1.70%
2008-12-31 $-0.34B $10.41B -3.02%
2008-09-30 $-1.60B $11.02B -14.11%
2008-06-30 $-1.64B $11.50B -16.81%
2008-03-31 $-1.54B $11.60B -19.31%
2007-12-31 $-1.16B $11.35B -18.96%
2007-09-30 $0.29B $4.48B 7.63%
2007-06-30 $0.22B $4.48B 6.84%
2007-03-31 $0.22B $4.25B 8.32%
2006-12-31 $0.29B $2.21B 14.28%
2006-09-30 $0.20B $2.04B 10.46%
2006-06-30 $0.16B $1.98B 8.42%
2006-03-31 $0.13B $1.87B 6.51%
2005-12-31 $0.13B $1.84B 6.29%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $17.841B $11.908B
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $52.630B 9.04
Teva Pharmaceutical Industries (TEVA) Israel $22.371B 6.85
Bausch Health Cos (BHC) Canada $8.219B 5.95
Dr Reddy's Laboratories (RDY) India $5.845B 23.34
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.568B 4.28
Supernus Pharmaceuticals (SUPN) United States $2.211B 20.95
Amphastar Pharmaceuticals (AMPH) United States $0.945B 102.55
Akorn (AKRX) United States $0.851B 0.00
Homology Medicines (FIXX) United States $0.720B 0.00
Assembly Biosciences (ASMB) United States $0.622B 0.00
CymaBay Therapeutics (CBAY) United States $0.531B 0.00
Corium (CORI) United States $0.459B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.439B 0.00
Voyager Therapeutics (VYGR) United States $0.377B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.275B 0.00
Sol-Gel Technologies (SLGL) Israel $0.129B 0.00
Teligent (TLGT) United States $0.117B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.089B 0.00
Aevi Genomic Medicine (GNMX) United States $0.069B 0.00
Acasti Pharma (ACST) Canada $0.053B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.052B 0.00
Evoke Pharma (EVOK) United States $0.043B 0.00
Agile Therapeutics (AGRX) United States $0.029B 0.00
China Pharma Holdings (CPHI) China $0.014B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.008B 0.00